All-case Japanese post-marketing surveillance of the real-world safety and efficacy of rituximab treatment in patients with refractory nephrotic syndrome
ConclusionThe safety and efficacy of rituximab treatment in patients with refractory nephrotic syndrome were confirmed in the real-world setting.Clinical trial registrationUMIN000014997.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research
More News: Clinical Trials | Drugs & Pharmacology | Japan Health | Nephrotic Syndrome | Pediatrics | Rituxan | Study | Urology & Nephrology